Edwards Lifesciences (EW) Debt Ratio (2009 - 2026)
Edwards Lifesciences' quarterly Debt Ratio came in at 0.04 in Q1 2026, down 2.13% year-on-year from 0.05 in Q1 2025, and up 2.86% quarter-over-quarter from 0.04 in Q4 2025.
Edwards Lifesciences has reported Debt Ratio for 18 years, with the latest figure at 0.04 in Q1 2026.
- For the quarter ending Q1 2026, Debt Ratio fell 2.13% year-over-year to 0.04; the trailing twelve-month figure through Mar 2026 stood at 0.04 (down 2.13% YoY), and the FY2025 full-year result was 0.04, down 4.59% from the prior year.
- Debt Ratio for Q1 2026 stood at 0.04, up from 0.04 in the prior quarter.
- The five-year high for Debt Ratio was 0.07 in Q4 2022, with the low at 0.04 in Q4 2025.
- Average Debt Ratio over 5 years is 0.06, with a median of 0.06 recorded in 2024.
- Year-over-year, Debt Ratio gained 2.64% in 2022 and fell 28.2% in 2024.
- Tracing EW's Debt Ratio over 5 years: stood at 0.07 in 2022, then slipped by 11.33% to 0.06 in 2023, then slipped by 28.2% to 0.05 in 2024, then retreated by 4.59% to 0.04 in 2025, then grew by 2.86% to 0.04 in 2026.
- The last three Debt Ratio figures came in at 0.04 (Q1 2026), 0.04 (Q4 2025), and 0.05 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Debt Ratio (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 0.31 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 0.32 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.31 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 0.25 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 0.04 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.25 |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 0.27 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 0.18 |
| 10 | Zimmer Biomet Holdings | 16.17 Bn | 15.75 Bn | 1.51 Bn | 0.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.04 |
| Dec 31, 2025 | 0.04 |
| Sep 30, 2025 | 0.05 |
| Jun 30, 2025 | 0.04 |
| Mar 31, 2025 | 0.05 |
| Dec 31, 2024 | 0.05 |
| Sep 30, 2024 | 0.05 |
| Jun 30, 2024 | 0.06 |
| Mar 31, 2024 | 0.06 |
| Dec 31, 2023 | 0.06 |
| Sep 30, 2023 | 0.06 |
| Jun 30, 2023 | 0.07 |
| Mar 31, 2023 | 0.07 |
| Dec 31, 2022 | 0.07 |
| Sep 30, 2022 | 0.07 |
| Jun 30, 2022 | 0.07 |
| Mar 31, 2022 | 0.07 |
| Dec 31, 2021 | 0.07 |
| Sep 30, 2021 | 0.07 |
| Jun 30, 2021 | 0.08 |
| Mar 31, 2021 | 0.08 |
| Dec 31, 2020 | 0.08 |
| Sep 30, 2020 | 0.09 |
| Jun 30, 2020 | 0.09 |
| Mar 31, 2020 | 0.10 |
| Dec 31, 2019 | 0.09 |
| Sep 30, 2019 | 0.10 |
| Jun 30, 2019 | 0.11 |
| Mar 31, 2019 | 0.11 |
| Dec 31, 2018 | 0.11 |
| Sep 30, 2018 | 0.10 |
| Jun 30, 2018 | 0.10 |
| Mar 31, 2018 | 0.18 |
| Dec 31, 2017 | 0.09 |
| Sep 30, 2017 | 0.20 |
| Jun 30, 2017 | 0.20 |
| Mar 31, 2017 | 0.18 |
| Dec 31, 2016 | 0.18 |
| Sep 30, 2016 | 0.14 |
| Jun 30, 2016 | 0.15 |
| Mar 31, 2016 | 0.16 |
| Dec 31, 2015 | 0.15 |
| Sep 30, 2015 | 0.16 |
| Jun 30, 2015 | 0.17 |
| Mar 31, 2015 | 0.17 |
| Dec 31, 2014 | 0.17 |
| Sep 30, 2014 | 0.18 |
| Jun 30, 2014 | 0.18 |
| Mar 31, 2014 | 0.27 |
| Dec 31, 2013 | 0.22 |
| Sep 30, 2013 | 0.21 |
| Jun 30, 2013 | 0.10 |
| Mar 31, 2013 | 0.08 |
| Dec 31, 2012 | 0.09 |
| Sep 30, 2012 | 0.08 |
| Jun 30, 2012 | 0.09 |
| Mar 31, 2012 | 0.09 |
| Dec 31, 2011 | 0.08 |
| Sep 30, 2011 | 0.09 |
| Jun 30, 2011 | 0.09 |
| Mar 31, 2011 | 0.08 |
| Dec 31, 2010 | 0.02 |
| Sep 30, 2010 | 0.06 |
| Jun 30, 2010 | 0.11 |
| Dec 31, 2009 | 0.06 |